Back
Also listed as
HKHHF
OTC
Day Range
$35.22
$35.41
52-Week Range
$33.58
$43.51
Volume
1,200
50D / 200D Avg
$38.75
/
$36.68
Prev Close
$35.68
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 20.7 | 10.5 |
| P/B | 2.3 | 1.2 |
| ROE % | 10.5 | 12.3 |
| Net Margin % | 3.3 | 5.3 |
| Rev Growth 5Y % | 7.0 | 5.5 |
| D/E | 2.2 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.00
$0.00 – $0.00
|
27 B | 0 |
| FY2026 |
$0.00
$0.00 – $0.00
|
26 B | 0 |
Key Takeaways
Revenue grew 6.99% annually over 5 years — modest growth
Earnings grew 91.16% over the past year
ROE of 10.48% — decent returns on equity
Debt/Equity of 2.23 — high leverage
Generating 2.61B in free cash flow
PEG of 0.20 suggests growth is underpriced
Growth
Revenue Growth (5Y)
6.99%
Revenue (1Y)-3.58%
Earnings (1Y)91.16%
FCF Growth (3Y)22.02%
Quality
Return on Equity
10.48%
ROIC9.16%
Net Margin3.31%
Op. Margin11.85%
Safety
Debt / Equity
2.23
Current Ratio0.93
Interest Coverage5.49
Valuation
P/E Ratio
20.66
P/B Ratio2.28
EV/EBITDA10.02
Dividend Yield0.07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.58% | Revenue Growth (3Y) | -2.69% |
| Earnings Growth (1Y) | 91.16% | Earnings Growth (3Y) | -9.95% |
| Revenue Growth (5Y) | 6.99% | Earnings Growth (5Y) | -13.02% |
| Profitability | |||
| Revenue (TTM) | 28.75B | Net Income (TTM) | 952.00M |
| ROE | 10.48% | ROA | 1.78% |
| Gross Margin | 35.78% | Operating Margin | 11.85% |
| Net Margin | 3.31% | Free Cash Flow (TTM) | 2.61B |
| ROIC | 9.16% | FCF Growth (3Y) | 22.02% |
| Safety | |||
| Debt / Equity | 2.23 | Current Ratio | 0.93 |
| Interest Coverage | 5.49 | Dividend Yield | 0.07% |
| Valuation | |||
| P/E Ratio | 20.66 | P/B Ratio | 2.28 |
| P/S Ratio | 0.68 | PEG Ratio | 0.20 |
| EV/EBITDA | 10.02 | Dividend Yield | 0.07% |
| Market Cap | 19.67B | Enterprise Value | 34.12B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 28.75B | 29.82B | 30.36B | 28.72B | 21.94B |
| Net Income | 952.00M | 498.00M | 1.17B | 1.34B | 1.66B |
| EPS (Diluted) | 1.70 | 0.88 | 2.07 | 2.33 | 2.89 |
| Gross Profit | 10.29B | 10.51B | 10.70B | 10.10B | 8.41B |
| Operating Income | 3.41B | 3.52B | 3.23B | 4.28B | 4.48B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 53.47B | 53.48B | 54.76B | 52.41B | 48.85B |
| Total Liabilities | 33.14B | 31.37B | 32.36B | 30.49B | 29.15B |
| Shareholders' Equity | 8.63B | 9.55B | 9.73B | 9.69B | 8.59B |
| Total Debt | 19.27B | 17.05B | 18.24B | 16.38B | 16.87B |
| Cash & Equivalents | 4.82B | 2.35B | 2.38B | 2.77B | 3.25B |
| Current Assets | 12.94B | 10.90B | 11.40B | 11.02B | 9.58B |
| Current Liabilities | 13.93B | 14.24B | 14.83B | 14.19B | 12.09B |